Markston International LLC cut its position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 2.6% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 168,353 shares of the pharmacy operator’s stock after selling 4,519 shares during the quarter. Markston International LLC’s holdings in Walgreens Boots Alliance were worth $7,136,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the stock. Public Employees Retirement Association of Colorado increased its position in shares of Walgreens Boots Alliance by 3.2% during the first quarter. Public Employees Retirement Association of Colorado now owns 143,590 shares of the pharmacy operator’s stock valued at $6,569,000 after purchasing an additional 4,471 shares during the period. Chicago Equity Partners LLC bought a new stake in shares of Walgreens Boots Alliance during the first quarter worth $223,000. Cetera Advisor Networks LLC raised its position in shares of Walgreens Boots Alliance by 80.2% during the first quarter. Cetera Advisor Networks LLC now owns 17,964 shares of the pharmacy operator’s stock worth $822,000 after acquiring an additional 7,997 shares during the last quarter. Cambridge Investment Research Advisors Inc. raised its position in shares of Walgreens Boots Alliance by 32.3% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 135,596 shares of the pharmacy operator’s stock worth $6,204,000 after acquiring an additional 33,116 shares during the last quarter. Finally, Aigen Investment Management LP increased its holdings in Walgreens Boots Alliance by 908.4% in the first quarter. Aigen Investment Management LP now owns 3,822 shares of the pharmacy operator’s stock valued at $175,000 after purchasing an additional 3,443 shares during the last quarter. Hedge funds and other institutional investors own 55.96% of the company’s stock.

Several equities research analysts have issued reports on WBA shares. Morgan Stanley lowered their price target on Walgreens Boots Alliance from $45.00 to $40.00 and set an “equal weight” rating for the company in a report on Thursday, September 3rd. Bank of America reduced their price target on Walgreens Boots Alliance from $43.00 to $40.00 and set an “underperform” rating for the company in a research report on Friday, July 10th. Raymond James reaffirmed a “hold” rating on shares of Walgreens Boots Alliance in a research report on Monday, September 7th. Credit Suisse Group cut their price objective on Walgreens Boots Alliance from $45.00 to $42.00 and set a “neutral” rating for the company in a research report on Thursday, August 27th. Finally, SunTrust Banks lowered their target price on Walgreens Boots Alliance from $42.00 to $40.00 and set a “hold” rating on the stock in a research note on Friday, July 10th. Four equities research analysts have rated the stock with a sell rating and fourteen have assigned a hold rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $44.60.

Shares of WBA traded down $0.28 on Friday, reaching $36.93. The company’s stock had a trading volume of 291,614 shares, compared to its average volume of 6,979,842. Walgreens Boots Alliance Inc has a 12-month low of $33.88 and a 12-month high of $64.50. The stock’s 50 day simple moving average is $39.19 and its two-hundred day simple moving average is $42.09. The company has a debt-to-equity ratio of 0.57, a current ratio of 0.69 and a quick ratio of 0.33. The stock has a market capitalization of $32.24 billion, a P/E ratio of 45.38, a PEG ratio of 1.35 and a beta of 0.43.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Thursday, July 9th. The pharmacy operator reported $0.83 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.10 by ($0.27). The business had revenue of $34.63 billion during the quarter, compared to analysts’ expectations of $34.32 billion. Walgreens Boots Alliance had a return on equity of 19.43% and a net margin of 0.55%. The company’s quarterly revenue was up .1% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.47 EPS. Analysts expect that Walgreens Boots Alliance Inc will post 4.68 earnings per share for the current year.

The company also recently declared a quarterly dividend, which was paid on Friday, September 11th. Investors of record on Wednesday, August 19th were issued a dividend of $0.4675 per share. This represents a $1.87 annualized dividend and a yield of 5.06%. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.46. The ex-dividend date was Tuesday, August 18th. Walgreens Boots Alliance’s dividend payout ratio is presently 31.22%.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Read More: Current Ratio

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.